Quantification of α(2A) and α(2C) adrenoceptors in the rat striatum and in different regions of the spinal cord

Acta Physiologica Scandinavica

Volumn 160, Issue 4, 1997, Pages 407-412

  Uhlén, Staffan ^a   Lindblom, J ^a   Tiger, G ^b   Wikberg, J E S ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Adrenoceptor; Cervical; Rat; Spinal cord; Striatum; Subtypes; 3H MK912; (2A), (2C)

Indexed keywords

1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; GUANFACINE; ISAGLIDOLE MALEATE; RECEPTOR SUBTYPE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; QUINOLIZINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; COMPUTER ANALYSIS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; ANIMAL; IN VITRO STUDY; KINETICS; METABOLISM; RADIOASSAY; RAT; SPRAGUE DAWLEY RAT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CORPUS STRIATUM; GUANFACINE; KINETICS; MALE; QUINOLIZINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; SPINAL CORD;

EID: 0030612047     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.1997.00175.x     Document Type: Article

References (23)

1. Armah, B.I. 1988. BDF 8933: A novel alpha-2-receptor antagonist lacking the potential to induce noradrenaline overflow. Naunyn-Schmiedebergs Arch Pharmacol 338, (suppl.), R55.
2. 2-noradrenergic mechanisms to prefrontal cortical cognitive function. Arch Gen Psychiatry 53, 448-455.
3. Bylund, D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo Jr R.R. & Trendelenburg U. 1994. IV. International union of pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46, 121-136.
4. 2-Adrenoceptors take centre stage at Nashville meeting. TIPS 17, 90-94.
5. 2-Adrenoceptor subtypes in the human brain: a pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections. Eur J Pharmacol 310, 83-93.
6. Lanier, S.M., Lafontan, M., Limbird, L.E. & Paris, H. 1996. Summary of the ASPET-sponsored Colloquium: Alpha-2 adrenergic receptors: structure, function, and therapeutic implications. J Pharmacol Exp Ther 277, 10-16.
7. Lawhead, R.G., Blaxall, H.S. & Bylund, D.B. 1992. Alpha-2 A is the predominant alpha-2 adrenergic receptor subtype in human spinal cord, Anaesthesiology 77 (5), 983-991.
8. 2-adrenergic receptor subtypes b and c. Science 273, 803-805.
9. Lowry, O.H., Rosebrough, N.J., Farr, A.L. & Randall, R.J. 1951, Protein measurement with the folin phenol reagent. J Biol Chem 193, 265-275.
10. Nicholas, A.P., Pieribone, V.A. & Hökfelt, T. 1993. Distribution of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study, J Comp Neurol 328, 575-594.
11. Nicholas, A.P., Pieribone, V.A., Dagerlind, Å., Meister, B., Elde, R. & Hökfelt, T. 1995. In situ hybridization. A complementary method to radioligandmediated autoradiography for localizing adrenergic, alpha-2 receptor-producing cells. Ann NY Acad Sci 763, 222-242.
12. Nicholas, A.P., Hökfelt, T. & Pieribone, V.A. 1996. The distribution and significance of CNS adrenoceptors examined with in situ hybridization. TIPS 17, 245-255.
13. 2 adrenoceptors in the human brain. J Pharmacol Exp Ther 2(2), 967-976.
14. Petrash, A.C. & Bylund, D.B. 1986. Alpha-2 adrenergic receptor subtypes indicated by (3H)yohimbine binding in human brain. Life Sci 38, 2129-2137.
15. Roudet, C., Mouchet, C. Feuerstein, C. & Savasta, M. 1994. Normal distribution of alpha 2-adrenoceptors in the rat spinal cord and its modification after noradrenergic denervation: a quantitative autoradiographic study. J Neurosci Res 39, 319-329.
16. 2-adrenergic receptor subtypes at four distinct levels. Mol Brain Res 34, 109-117.
17. Takano, Y. & Yaksh, T.L. 1992. Characterization of the pharmacology of intrathecally administered &-2 agonists and antagonists in rats. J Pharmacol Exp Ther 261 (2), 764-772.
18. 2A-adrenoceptors inhibit the release of endogenous dopamine in the rabbit caudate nucleus slices. Naunyn-Schmietieherg's Arch Pharmacol 350 (5), 473-481.
19. 2C subtype mediate inhibition of norepinephrine release in human kidney cortex. Mol Pharmacol 45, 1168-1176.
20. 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using HRX821002 ligand binding. Pharmacol Toxicol 69, 341-350.
21. 2A-selective compound, Eur J Pharmacol 202, 235-243.
22. 2-adrenoceptor. Br J Pharmacol 106, 986-995.
23. 2C-adrenoceptors. J Pharmacol Exp Ther 271 (3), 1558-1565.